Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report

BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Koie, Takuya, Ohyama, Chikara, Okamoto, Akiko, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222084/
https://www.ncbi.nlm.nih.gov/pubmed/24267160
http://dx.doi.org/10.1186/1756-0500-6-484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222084/
https://www.ncbi.nlm.nih.gov/pubmed/24267160
http://dx.doi.org/10.1186/1756-0500-6-484

Ejemplares similares